Kyowa launches rapid TB (tuberculosis) test in Japan:
This article was originally published in Clinica
Kyowa Medex has launched its Determiner TBGL blood test for TB and atypical mycobacteria infection in Japan. The test, which produces results within two and a half hours, is claimed to be more accurate than sputum tests, with around 81% detection rate. Based on an antibody reaction to TBGL surface antigen, the product was originally developed by Sawai and Osaka City University. Outside Japan it will be sold by Sumisho Pharma International, a Sumitomo affiliate, initially in South Korea and Taiwan.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.